Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Return on Assets [ROA] (2009 - 2026)

Updated

Vistagen Therapeutics (VTGN) recorded Return on Assets [ROA] of -199.36% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 116.29 percentage points from -83.07% a year earlier and down 38.91 percentage points from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics reported Return on Assets [ROA] of -104.87%, down 55.44 percentage points from FY2025.

  • Annual Return on Assets [ROA] has a five-year change of -73.43 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, Return on Assets [ROA] came in at -49.44% in FY2025 (-8.87 pp), -40.57% in FY2024 (+83.21 pp), -123.78% in FY2023 (-71.56 pp) and -52.22% in FY2022 (-20.77 pp).
  • The fiscal Q2 2027 figure is the lowest quarterly Return on Assets [ROA] since fiscal Q1 2024.
  • On a year-over-year basis, Return on Assets [ROA] has declined for eight consecutive quarters, with an average year-over-year change of -56.21 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 228.79 percentage points in fiscal Q1 2025, against a drop of 175.44 percentage points in fiscal Q4 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -160.45% (Q1 2027), -122.68% (Q4 2026) and -91.85% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -361.97%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 19.00%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 8.08%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 7.32%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 1.87%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 9.80%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -7.67%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -199.36%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -199.36%
Jun 30, 2026 -160.45%
Mar 31, 2026 -122.68%
Dec 31, 2025 -91.85%
Sep 30, 2025 -83.07%
Jun 30, 2025 -72.79%
Mar 31, 2025 -58.21%
Dec 31, 2024 -48.55%
Sep 30, 2024 -36.61%
Jun 30, 2024 -27.98%
Mar 31, 2024 -23.05%
Dec 31, 2023 -37.02%
Sep 30, 2023 -123.99%
Jun 30, 2023 -256.77%
Mar 31, 2023 -233.27%
Dec 31, 2022 -180.96%
Sep 30, 2022 -129.71%
Jun 30, 2022 -89.67%
Mar 31, 2022 -57.83%
Dec 31, 2021 -39.03%
API Access

Vistagen Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEY